Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Journal of Bacteriology|November 1, 1986
Isolation of a Fusarium solani mutant reduced in cutinase activity and virulenceA H Dantzig, S H Zuckerman, M M Andonov-RolandSomatic Cell and Molecular Genetics|March 1, 1984
Isolation and characterization of a CHO amino acid transport mutant resistant to melphalan (L-phenylalanine mustard)A H Dantzig, M Fairgrieve, C W Slayman, et al.Current Medicinal Chemistry|February 15, 2001
Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinicA H Dantzig, K L Law, J Cao, et al.Journal of Bacteriology|February 1, 1978
Induction and repression of nitrate reductase in Neurospora crassaA H Dantzig, W K Zurowski, T M Ball, et al.International Journal of Cancer|November 28, 2002
Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979Robert L Shepard, Jin Cao, James J Starling, et al.Histopathology|July 18, 2002
Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarraysG E Sandusky, K S Mintze, S E Pratt, et al.Journal of Pharmaceutical Sciences|July 1, 1996
Uptake characteristics of loracarbef and cephalexin in the Caco-2 cell culture model: effects of the proton gradient and possible presence of a distinctive second componentM Hu, J Chen, L Zheng, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 13, 2005
Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transportSusan Pratt, Victor Chen, William I Perry, et al.Somatic Cell and Molecular Genetics|September 1, 1987
Isolation and characterization of a glycine transport mutant in an established mammalian cell line, CHO(PEOT/1)M Fairgrieve, J M Mullin, A H Dantzig, et al.Biochemical Pharmacology|October 24, 1991
Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H(+)-K+)-ATPaseA H Dantzig, P L Minor, J L Garrigus, et al.Pageof 6